Diagnostic Confirmation for Sarcoidosis
For patients with a high clinical suspicion of sarcoidosis (e.g., Löfgren's syndrome, lupus pernio, or Heerfordt's syndrome), no additional investigations are needed to confirm the diagnosis. 1
Clinical Presentation-Based Approach
High Clinical Suspicion Cases (No Additional Testing Needed)
- In patients presenting with classic syndromes such as Löfgren's syndrome (erythema nodosum, fever, arthralgia, bilateral hilar lymphadenopathy), lupus pernio (violaceous facial lesions), or Heerfordt's syndrome (fever, parotid enlargement, uveitis, facial nerve palsy), lymph node sampling is not recommended 1, 2
- These presentations are considered highly specific for sarcoidosis and do not require histological confirmation 3
- Close clinical follow-up is essential when biopsy is deferred 1
Moderate Clinical Suspicion Cases
- For patients with asymptomatic bilateral hilar lymphadenopathy without classic syndromes, the American Thoracic Society makes no firm recommendation for or against lymph node sampling 1, 2
- If lymph node sampling is not performed, close clinical follow-up is considered a reasonable alternative approach 1
- Be aware that in patients with suspected stage 1 sarcoidosis, while 85% are confirmed to have sarcoidosis, alternative diagnoses include tuberculosis (38%) and lymphoma (25%) 1, 2
Recommended Baseline Testing for Confirmed Sarcoidosis
When sarcoidosis is diagnosed, the following baseline tests are recommended to screen for potential organ involvement:
- Serum calcium (strong recommendation) - to screen for abnormal calcium metabolism even in asymptomatic patients 1
- Serum creatinine - to screen for renal sarcoidosis even without renal symptoms 1
- Serum alkaline phosphatase - to screen for hepatic sarcoidosis even without hepatic symptoms 1
- Baseline ECG - to screen for possible cardiac involvement even without cardiac symptoms 1, 4
- Ophthalmologic examination - to screen for ocular sarcoidosis even in asymptomatic patients 1
When Tissue Sampling Is Indicated
If the clinical presentation is not classic and tissue sampling is deemed necessary:
- EBUS-guided lymph node sampling has a diagnostic yield of 87% with minimal complications (<0.1%) 1, 2
- Mediastinoscopy has a higher diagnostic yield (98%) but is more invasive 1
- The diagnosis requires histopathological evidence of non-necrotizing granulomas and exclusion of alternative causes of granulomatous inflammation 1, 3
Important Considerations
- Sarcoidosis diagnosis is based on three major criteria: compatible clinical/radiological presentation, histological evidence of non-necrotizing granulomas, and exclusion of alternative diagnoses 1, 5
- The diagnosis is never fully secure due to lack of universally accepted measures to determine if each diagnostic criterion has been satisfied 1
- Pulmonary function tests should be performed to assess for restrictive physiology and impaired gas exchange 2, 6
- Tuberculosis testing (interferon-gamma release assay or tuberculin skin test) should be performed to exclude this alternative diagnosis 2
Pitfalls to Avoid
- Failing to consider alternative diagnoses such as tuberculosis, lymphoma, or fungal infections, which can mimic sarcoidosis 1, 2, 7
- Overlooking cardiac sarcoidosis, which can be life-threatening but may be clinically silent 4, 6
- Neglecting to screen for extrapulmonary manifestations, which occur in 25-50% of patients 3, 8
- Relying solely on serum ACE levels for diagnosis, as this test lacks sensitivity and specificity 5, 7